
In this article, we address some of the statistical issues associated with the next generation of zzso clinical zzso Specifically, we focus on two critical aspects of zzso clinical zzso study zzso and study zzso In our discussion of study zzso we provide an overview of zzso relevant to each phase of clinical trials zzso I, II, and zzso and discuss some of the trends in selecting zzso in recent zzso For phase I designs, the traditional assumption that increasing dose will always lead to increasing zzso appropriate for zzso agents, is not zzso to novel zzso such as in zzso zzso We emphasize the role of surrogate zzso in modern clinical zzso In our discussion of study design, we are particularly interested in the essential role of zzso and discuss recently developed zzso phase II zzso We consider the role zzso play in the design of clinical trials and introduce study designs for zzso zzso Finally, we briefly discuss the application of zzso designs in clinical zzso 

